Suppr超能文献

多种硫酸酯酶缺乏症的晚婴型伴 SUMF1 基因新型错义变异:病例报告和综述。

Late infantile form of multiple sulfatase deficiency with a novel missense variant in the SUMF1 gene: case report and review.

机构信息

FRIGE's Institute of Human Genetics, FRIGE House, Jodhpur Gam Road, Satellite, Ahmedabad, India.

Royal Institute of Child Neurosciences, Vastrapur, Ahmedabad, India.

出版信息

BMC Pediatr. 2023 Mar 24;23(1):133. doi: 10.1186/s12887-023-03955-w.

Abstract

BACKGROUND

Multiple sulfatase deficiency (MSD) is a rare lysosomal storage disorder caused due to pathogenic variants in the SUMF1 gene. The SUMF1 gene encodes for formylglycine generating enzyme (FGE) that is involved in the catalytic activation of the family of sulfatases. The affected patients present with a wide spectrum of clinical features including multi-organ involvement. To date, almost 140 cases of MSD have been reported worldwide, with only four cases reported from India. The present study describes two cases of late infantile form of MSD from India and the identification of a novel missense variant in the SUMF1 gene.

CASE PRESENTATION

In case 1, a male child presented to us at the age of 6 years. The remarkable presenting features included ichthyosis, presence of irritability, poor social response, thinning of corpus callosum on MRI and, speech regression. Clinical suspicion of MSD was confirmed by enzyme analysis of two sulfatase enzymes followed by gene sequencing. We identified a novel missense variant c.860A > T (p.Asn287Ile) in exon 7 of the SUMF1 gene. In case 2, a two and a half years male child presented with ichthyosis, leukodystrophy and facial dysmorphism. We performed an enzyme assay for two sulfatases, which showed significantly reduced activities thereby confirming MSD diagnosis.

CONCLUSION

Overall, present study has added to the existing data on MSD from India. Based on the computational analysis, the novel variant c.860A > T identified in this study is likely to be associated with a milder phenotype and prolonged survival.

摘要

背景

多种硫酸酯酶缺乏症(MSD)是一种罕见的溶酶体贮积病,由 SUMF1 基因的致病性变异引起。SUMF1 基因编码甲酰甘氨酸生成酶(FGE),该酶参与硫酸酯酶家族的催化激活。受影响的患者表现出广泛的临床特征,包括多器官受累。迄今为止,全世界已报告了近 140 例 MSD 病例,而印度仅报告了 4 例。本研究描述了来自印度的两例晚发性婴儿 MSD 病例,并鉴定了 SUMF1 基因中的一种新的错义变异。

病例介绍

在病例 1 中,一名男性患儿在 6 岁时就诊于我们。显著的表现特征包括鱼鳞癣、易激惹、社会反应差、磁共振成像上胼胝体变薄和言语退化。通过对两种硫酸酯酶进行酶分析,随后进行基因测序,确认了 MSD 的临床怀疑。我们在 SUMF1 基因的外显子 7 中鉴定了一种新的错义变异 c.860A>T(p.Asn287Ile)。在病例 2 中,一名两岁半的男童表现为鱼鳞癣、白质营养不良和面部畸形。我们进行了两种硫酸酯酶的酶活性测定,结果显示活性显著降低,从而确认了 MSD 的诊断。

结论

总体而言,本研究增加了印度 MSD 的现有数据。基于计算分析,本研究中鉴定的新变异 c.860A>T 可能与更温和的表型和更长的生存期相关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2fa2/10037891/921fcd9f850a/12887_2023_3955_Fig1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验